Browser storage is unavailable. Keep this page open and export your collection before leaving.
Massive Bio
Overview
Developer of an artificial intelligence-driven platform intended to connect cancer patients to biopharmaceutical clinical trials. The company offers tech-enabled services and a big data platform that addresses the clinical trial enrollment value chain by providing patient identification, pre-screening, and concierge enrollment enablement while being focused on oncology and innovative data, technology, and services, enabling patients to get an effective treatment without disrupting lives and becoming a financial hindrance.
News & product activity
Sources & observations
Maturity: Not assessed · 2 of 6 areas documented
Source-based assessment · automated evidence rules
The retained text does not establish product availability or customer use.
Maturity is an evidence-based assessment, not a success rating. It may understate the current stage where evidence is limited. Coverage records documented areas, not a complete or independently audited company history.
- Product overviewSource description Checked 2026-11-11
- Product visualsNot documented
- Founders & originsNot documented
- Business model & pricingNot documented
- Funding & ownershipNot documented
- Dated milestonesDated source activity: 2016 (year only)





